312 related articles for article (PubMed ID: 27715007)
1. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D
Whiting RL; Choppin A; Luehr G; Jasper JR
J Pharmacol Exp Ther; 2021 Oct; 379(1):85-95. PubMed ID: 34253646
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of D2 and D3 receptors during reinstatement of cocaine-seeking behavior in the Roman high- and low-avoidance rats.
Dimiziani A; Bellés Añó L; Tsartsalis S; Millet P; Herrmann F; Ginovart N
Behav Neurosci; 2019 Feb; 133(1):77-85. PubMed ID: 30489132
[TBL] [Abstract][Full Text] [Related]
4. Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking.
Sabioni P; Di Ciano P; Le Foll B
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():149-54. PubMed ID: 26279138
[TBL] [Abstract][Full Text] [Related]
5. The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.
You ZB; Gao JT; Bi GH; He Y; Boateng C; Cao J; Gardner EL; Newman AH; Xi ZX
Neuropharmacology; 2017 Nov; 126():190-199. PubMed ID: 28888944
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior.
Wager TT; Chandrasekaran RY; Bradley J; Rubitski D; Berke H; Mente S; Butler T; Doran A; Chang C; Fisher K; Knafels J; Liu S; Ohren J; Marconi M; DeMarco G; Sneed B; Walton K; Horton D; Rosado A; Mead A
ACS Chem Neurosci; 2014 Dec; 5(12):1253-65. PubMed ID: 25299732
[TBL] [Abstract][Full Text] [Related]
7. Effects of Acute and Chronic Treatments with Dopamine D
Thomsen M; Barrett AC; Butler P; Negus SS; Caine SB
J Pharmacol Exp Ther; 2017 Jul; 362(1):161-176. PubMed ID: 28473458
[TBL] [Abstract][Full Text] [Related]
8. Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist.
Lopak V; Erb S
Psychopharmacology (Berl); 2005 Oct; 182(2):297-304. PubMed ID: 16010538
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.
Ananthan S; Saini SK; Zhou G; Hobrath JV; Padmalayam I; Zhai L; Bostwick JR; Antonio T; Reith ME; McDowell S; Cho E; McAleer L; Taylor M; Luedtke RR
J Med Chem; 2014 Aug; 57(16):7042-60. PubMed ID: 25126833
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands.
Cao Y; Min C; Acharya S; Kim KM; Cheon SH
Bioorg Med Chem; 2016 Jan; 24(2):191-200. PubMed ID: 26707842
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.
Vorel SR; Ashby CR; Paul M; Liu X; Hayes R; Hagan JJ; Middlemiss DN; Stemp G; Gardner EL
J Neurosci; 2002 Nov; 22(21):9595-603. PubMed ID: 12417684
[TBL] [Abstract][Full Text] [Related]
12. Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range.
Baba S; Enomoto T; Horisawa T; Hashimoto T; Ono M
J Pharmacol Sci; 2015 Mar; 127(3):326-31. PubMed ID: 25837930
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
[TBL] [Abstract][Full Text] [Related]
14. The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions.
Venkatachalam K; Eissa N; Awad MA; Jayaprakash P; Zhong S; Stölting F; Stark H; Sadek B
Biomed Pharmacother; 2021 Jun; 138():111517. PubMed ID: 33773463
[TBL] [Abstract][Full Text] [Related]
15. Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55.
Cheung TH; Loriaux AL; Weber SM; Chandler KN; Lenz JD; Schaan RF; Mach RH; Luedtke RR; Neisewander JL
J Pharmacol Exp Ther; 2013 Nov; 347(2):410-23. PubMed ID: 24018640
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
[TBL] [Abstract][Full Text] [Related]
17. Selective D
Manvich DF; Petko AK; Branco RC; Foster SL; Porter-Stransky KA; Stout KA; Newman AH; Miller GW; Paladini CA; Weinshenker D
Neuropsychopharmacology; 2019 Jul; 44(8):1445-1455. PubMed ID: 30879021
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D
Free RB; Cuoco CA; Xie B; Namkung Y; Prabhu VV; Willette BKA; Day MM; Sanchez-Soto M; Lane JR; Laporte SA; Shi L; Allen JE; Sibley DR
Mol Pharmacol; 2021 Oct; 100(4):372-387. PubMed ID: 34353882
[TBL] [Abstract][Full Text] [Related]
19. A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats.
Chen Y; Song R; Yang RF; Wu N; Li J
Eur J Pharmacol; 2014 Nov; 743():126-32. PubMed ID: 25261038
[TBL] [Abstract][Full Text] [Related]
20. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking.
Anderson SM; Schmidt HD; Pierce RC
Neuropsychopharmacology; 2006 Jul; 31(7):1452-61. PubMed ID: 16205775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
